Murine models for pharmacological studies of the metabolic syndrome

Published on Mar 1, 2013in Pharmacology & Therapeutics10.557
· DOI :10.1016/J.PHARMTHERA.2012.11.004
Lyne Fellmann6
Estimated H-index: 6
(UDS: University of Strasbourg),
Alessandro R. Nascimento6
Estimated H-index: 6
(FIOCRUZ: Oswaldo Cruz Foundation)
+ 1 AuthorsPascal Bousquet32
Estimated H-index: 32
(UDS: University of Strasbourg)
Sources
Abstract
Metabolic syndrome has been described as the association of insulin resistance, hypertension, hyperlipidemia and obesity. Its prevalence increased dramatically, mainly in developed countries. Animal models are essential to understand the pathophysiology of this syndrome. This review presents the murine models of metabolic syndrome the most often used in pharmacological studies. The most common metabolic syndrome models exhibit a non-functional leptin pathway, or metabolic disorders induced by high fat diets. In a first part, and after a short introduction on leptin, its receptor and mechanism of action, we provide a detailed description of each model: SHROB, SHHF, JCR:LA-cp, Zucker, ZDF, Wistar Ottawa Karlsburg W, and Otsuka Long-Evans Tokushima Fatty rats, ob/ob, db/db, agouti yellow and Mc4R KO mice. The second part of this review is dedicated to metabolic syndrome models obtained by high fat feeding.
📖 Papers frequently viewed together
202 Citations
102 Citations
773 Citations
References216
Newest
#1Antonio CittadiniH-Index: 41
#2R. Napoli (University of Naples Federico II)H-Index: 1
Last. Luigi Saccà (University of Naples Federico II)H-Index: 60
view all 11 authors...
Insulin resistance is a recently identified mechanism involved in the pathophysiology of chronic heart failure (CHF). We investigated the effects of two insulin-sensitizing drugs (metformin and rosiglitazone) in a genetic model of spontaneously hypertensive, insulin-resistant rats (SHHF). Thirty SHHF rats were randomized into three treatment groups as follows: 1) metformin (100 mg/kg per day), 2) rosiglitazone (2 mg/kg per day), and 3) no drug. Ten Sprague-Dawley rats served as normal controls. ...
94 CitationsSource
#1Viviane Trak-Smayra (""St. Joe's"": Saint Joseph's University)H-Index: 7
#2Valérie Paradis (Beaujon Hospital)H-Index: 87
Last. Bernard Fromenty (University of Rennes)H-Index: 65
view all 6 authors...
Non-alcoholic fatty liver disease (NAFLD) is one of the commonest liver diseases in Western countries. Although leptin deficient ob/ob and db/db mice are frequently used as murine models of NAFLD, an exhaustive characterization of their hepatic lesions has not been reported to date, particularly under calorie overconsumption. Thus, liver lesions were characterized in 78 ob/ob and db/db mice fed either a standard or high-calorie (HC) diet, for one or three months. Steatosis, necroinflammation, ap...
85 CitationsSource
#1Yukinori Tamura (Kyoto University)H-Index: 17
#2Toshinori MurayamaH-Index: 21
Last. Hidenori Arai (Kyoto University)H-Index: 72
view all 5 authors...
Recent studies suggest a potential benefit of the lipid-lowering medication in the treatment of chronic kidney disease (CKD) such as diabetic nephropathy. Although statins have been widely used to lower serum cholesterol levels, the effect of these drugs on diabetic nephropathy has not been fully elucidated. In the present study, therefore, we addressed the role of different kinds of statins on diabetic nephropathy in db/db mice. Mice were fed with a standard diet with 0.005% (w/w) of pitavastat...
15 CitationsSource
#1Amal Ait-Omar (UPMC: Pierre-and-Marie-Curie University)H-Index: 1
#2Milena Monteiro-Sepulveda (UPMC: Pierre-and-Marie-Curie University)H-Index: 2
Last. Edith Brot-Laroche (UPMC: Pierre-and-Marie-Curie University)H-Index: 22
view all 18 authors...
OBJECTIVE In healthy rodents, intestinal sugar absorption in response to sugar-rich meals and insulin is regulated by GLUT2 in enterocyte plasma membranes. Loss of insulin action maintains apical GLUT2 location. In human enterocytes, apical GLUT2 location has not been reported but may be revealed under conditions of insulin resistance. RESEARCH DESIGN AND METHODS Subcellular location of GLUT2 in jejunal enterocytes was analyzed by confocal and electron microscopy imaging and Western blot in 62 w...
96 CitationsSource
#1Flavia M. Souza-Smith (UFES: Universidade Federal do Espírito Santo)H-Index: 13
#2Paige S. Katz (OSU: Ohio State University)H-Index: 12
Last. Pamela A. Lucchesi (OSU: Ohio State University)H-Index: 32
view all 8 authors...
Objective Resistance vessel remodeling is controlled by myriad of hemodynamic and neurohormonal factors. This study characterized structural and molecular remodeling in mesenteric resistance arteries (MRAs) in diabetic (db/db) and control (Db/db) mice.
37 CitationsSource
#1Monika Ivanová (SAV: Slovak Academy of Sciences)H-Index: 4
#2Pavol Janega (Comenius University in Bratislava)H-Index: 17
Last. Miroslav Barancik (SAV: Slovak Academy of Sciences)H-Index: 25
view all 7 authors...
Abstract High-fat or high-carbohydrate food consumption contributes to changes in myocardial tolerance to ischemia. However, with respect to experimental models, most studies used diets with very high doses of cholesterol, saturated fatty acids, or fructose. In our study, we fed rats a high-fat diet based on lard in combination with administration of a sweet beverage (30% sucrose solution) (high-fat sucrose diet [HFS]). This diet was used to simulate the unhealthy dietary habit typical for devel...
10 CitationsSource
#1Hiroyuki ShimizuH-Index: 59
#2Takafumi TsuchiyaH-Index: 11
Last. Masatomo MoriH-Index: 84
view all 9 authors...
Obese people show marked hyerinsulinemia, but the exact mechanism has not been clarified. Hyperleptinemia is one possible candidate, although there is an obvious difference in the effect of leptin on insulin secretion between isolated pancreatic islets and β-cell line. Since glucagon may modulate the effect of leptin on insulin secretion, we determined the influences of glucagon in the leptin effect on insulin secretion. The influences of glucagon in the leptin effect on insulin secretion for 10...
3 CitationsSource
#1Matthew R. Hayes (UPenn: University of Pennsylvania)H-Index: 43
#2Scott E. Kanoski (UPenn: University of Pennsylvania)H-Index: 37
Last. Harvey J. Grill (UPenn: University of Pennsylvania)H-Index: 72
view all 4 authors...
The glucagon-like-peptide-1 receptor (GLP-1R) agonists, liraglutide (Victoza) and the synthetic product of exendin-4 (Byetta), are approved for type II diabetes mellitus (T2DM) treatment and may be efficacious in obesity treatment as well, in part, due to the drugs' resistance to enzymatic degradation and prolonged half-life relative to endogenous GLP-1. To address the need to directly compare the food intake- and body weight-suppressive effects of these two GLP-1R ligands, acute and chronic dos...
80 CitationsSource
#1Brante P. Sampey (UNC: University of North Carolina at Chapel Hill)H-Index: 6
#2Amanda M. Vanhoose (UNC: University of North Carolina at Chapel Hill)H-Index: 1
Last. Liza Makowski (UNC: University of North Carolina at Chapel Hill)H-Index: 35
view all 8 authors...
Obesity has reached epidemic proportions worldwide and reports estimate that American children consume up to 25% of calories from snacks. Several animal models of obesity exist, but studies are lacking that compare high-fat diets (HFD) traditionally used in rodent models of diet-induced obesity (DIO) to diets consisting of food regularly consumed by humans, including high-salt, high-fat, low-fiber, energy dense foods such as cookies, chips, and processed meats. To investigate the obesogenic and ...
402 CitationsSource
#1Masato Suzuki (Jikei University School of Medicine)H-Index: 9
#2Daisuke Shindo (Jikei University School of Medicine)H-Index: 4
Last. Hidefumi Waki (Wakayama Medical University)H-Index: 23
view all 4 authors...
This study was conducted to assess the effects of exercise, diet, and their combination on metabolic syndrome (MS) risk factors including visceral fat mass (VFM), glucose intolerance, and dyslipidemia in OLETF rats. Thirty-two male rats were assigned to exercise (OLETF-Ex), dietary treatment (-DT), combination (-Ex&DT), or sedentary (-Sed) groups. Daily voluntary exercise using a rotary wheel was performed in OLETF-Ex. Each treatment was conducted from 21 to 31 wk of age. An oral glucose toleran...
13 CitationsSource
Cited By95
Newest
Abstract Objective The paper studied the effects of Rhynchophylline on the leptin-mediated JAK2/STAT3 pathway in hypothalamus. Using the leptin / leptin receptor and leptin-mediated JAK2/STAT3 pathway as an entry point, the research evaluated the effect of the hypotensive drug, and clarified the preliminary mechanism, expecting to provide new therapeutic ideas for essentially improving obese hypertension, balancing the body's neuro-endocrine function, and preventing the occurrence of cardiovascu...
Source
#1Marilén Federico (CONICET: National Scientific and Technical Research Council)H-Index: 2
#2Sergio de la Fuente (Thomas Jefferson University)H-Index: 11
Last. Shey-Shing Sheu (Thomas Jefferson University)H-Index: 60
view all 4 authors...
Metabolic diseases (MetD) embrace a series of pathologies characterize by abnormal body glucose usage. The known diseases included in this group are metabolic syndrome, prediabetes and diabetes mellitus type 1 and 2, all of them are chronic pathologies that present metabolic disturbances and are classified as multi-organ diseases. Cardiomyopathy has been extensively described in diabetic patients without overt macrovascular complications. The heart is severely damaged during the progression of t...
1 CitationsSource
Source
#1Maud Weiss (UDS: University of Strasbourg)H-Index: 3
#2Lyne Fellmann (UDS: University of Strasbourg)H-Index: 6
Last. Nathalie Niederhoffer (UDS: University of Strasbourg)H-Index: 6
view all 6 authors...
BACKGROUND/OBJECTIVES Overweight and obesity are undoubtable risk factors for type 2 diabetes and cardiovascular diseases and significantly contribute to the global morbi-mortality. We previoulsy reported that LNP599, a pharmacological imidazoline-like activator of hepatic AMPK/adiponectin signaling, protects against the development of adiposity and obesity and the associated cardio-metabolic disorders, suggesting that it may be a suitable drug candidate for a therapeutic approach targeting the ...
Source
#1Michele Ciccarelli (UNISA: University of Salerno)H-Index: 29
#2Dana Dawson (Aberd.: University of Aberdeen)H-Index: 29
Last. Thomas Thum (UNISA: University of Salerno)
view all 13 authors...
Heart failure-either with reduced or preserved ejection fraction (HFrEF/HFpEF)-is a clinical syndrome of multifactorial and gender-dependent aetiology, indicating the insufficiency of the heart to pump blood adequately to maintain blood flow to meet the body's needs. Typical symptoms commonly include shortness of breath, excessive fatigue with impaired exercise capacity, and peripheral oedema, thereby alluding to the fact that heart failure is a syndrome that affects multiple organ systems. Pati...
Source
view all 3 authors...
Source
view all 3 authors...
Source
Nonalcoholic fatty liver disease (NAFLD) is a continuum of liver abnormalities often starting as simple steatosis and to potentially progress into nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis and hepatocellular carcinoma. Because of its increasing prevalence, NAFLD is becoming a major public health concern, in parallel with a worldwide increase in the recurrence rate of diabetes and metabolic syndrome. It has been estimated that NASH cirrhosis may surpass viral hepatitis C and become...
5 CitationsSource
#1Bianca F Leonardi (UFRGS: Universidade Federal do Rio Grande do Sul)H-Index: 4
#2Grace Gosmann (UFRGS: Universidade Federal do Rio Grande do Sul)H-Index: 28
Last. Aline Rigon Zimmer (UFRGS: Universidade Federal do Rio Grande do Sul)H-Index: 10
view all 3 authors...
Standardized animal models represent one of the most valuable tools available to understand the mechanism underlying the metabolic syndrome (MetS) and to seek for new therapeutic strategies. However, there is considerable variability in the studies conducted with this essential purpose. This review presents an updated discussion of the most recent studies using diverse experimental conditions to induce MetS in rodents with unbalanced diets, discusses the key findings in metabolic outcomes, and c...
Source
#1Weisheng Lu (CPU: China Pharmaceutical University)H-Index: 4
#2Hong Tian (CPU: China Pharmaceutical University)H-Index: 10
Last. Wenbing Yao (CPU: China Pharmaceutical University)H-Index: 25
view all 9 authors...
BACKGROUND AND PURPOSE: Type 2 diabetes is one of the most severe chronic diseases and is becoming an increasingly serious public health trouble worldwide. There are several glucagon-like peptide-1 receptor agonists (GLP-1RAs) were developed to treat the type 2 diabetes. However, most of them are injectable form, which immensely reduce the tolerance of patients and increase the risk of infection. Here, we designed a novel orally available GLP-1RA with only replacing the amino acids in exendin-4,...
1 CitationsSource